P eriprosthetic osteolysis is a major cause of aseptic loosening in artificial joint replacement. It is assumed to occur in conjunction with the activation of macrophages. We have shown in vitro that human osteoblast-like cells, isolated from bone specimens obtained from patients undergoing hip replacement, phagocytose fine particles of titanium alloy (TiAlV).
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From the Georg-August-University, Goettingen, Germany P eriprosthetic osteolysis is a major cause of aseptic loosening in artificial joint replacement. It is assumed to occur in conjunction with the activation of macrophages. We have shown in vitro that human osteoblast-like cells, isolated from bone specimens obtained from patients undergoing hip replacement, phagocytose fine particles of titanium alloy (TiAlV).
The human osteoblast-like cells were identified immunocytochemically by the presence of bone-specific alkaline phosphatase (BAP). With increasing duration of culture, a variable number of the osteoblastic cells became positive for the macrophage marker CD68, independent of the phagocytosis of particles, with a fine granular cytoplasmic staining which was coexpressed with BAP as revealed by immunodoublestaining. The metal particles were not toxic to the osteoblastic cells since even in culture for up to four weeks massively laden cells were vital and had a characteristic morphology. Cells of the human osteosarcoma cell line (HOS 58) were also able to phagocytose metal particles but had only a low expression of the CD68 antigen. Fluorescence-activated cell scanning confirmed our immunocytochemical results. Additionally, the cells were found to be negative for the major histocompatibility complex-II (MHC-II) which is a marker for macrophages and other antigen-presenting cells. Negative results of histochemical tests for tartrate-resistant acid phosphatase excluded the contamination by osteoclasts or macrophages in culture.
Our observations suggest that the osteoblast can either change to a phagocytosing cell or that the phagocytosis is an underestimated property of the osteoblast. The detection of the CD68 antigen is insufficient to prove the monocytic lineage. In order to discriminate between macrophages and osteoblasts additional markers should be used. To our knowledge, this is the first demonstration of cells of an osteoblastic origin which have acquired a mixed phenotype of both osteoblasts and macrophages.
debris is generally accepted to be responsible for the recruitment of monocytes/macrophages and the formation of foreign-body granulomas. Phagocytosis of wear particles by macrophages stimulates these cells to produce and secrete inflammatory mediators 5, 6 which have been implicated in the stimulation of bone resorption. 7, 8 The role of osteoblasts in contact with wear particles is poorly understood. We have investigated the behaviour of cultured human osteoblast-like cells when exposed to metal particles in vitro. To exclude the presence of cells of myeloid origin, we also studied markers such as CD68, tartrate-resistant acid phosphatase (TRAP) and major histocompatibility complex II (MHC II). CD68 is used as a panmonocyte/macrophage marker and identifies the myeloid origin of a cell. 9, 10 TRAP is physiologically present in alveolar macrophages and osteoclasts and is also found in activated macrophages. 11 MHC II is expressed on antigenpresenting cells which include macrophages and dendritic cells. 12 For comparison, the human osteosarcoma cell line HOS 58 was treated under identical conditions. We found that both types of cell phagocytosed metal particles. We were also able to show a coexpression of the macrophage marker CD68 and bone-specific alkaline phosphatase (BAP) in primary osteoblastic cells whereas for TRAP and MHC II the cells were negative. Furthermore, we found an increasing expression of CD68 which was dependent on the time of culture, but independent of phagocytosis of metal particles.
Materials and Methods
Bone preparation and cell culture. Specimens of bone tissue were obtained from four patients aged between 50 and 65 years who were undergoing total hip replacement because of primary osteoarthritis. The tissues were obtained from material which is routinely removed from the medullary cavity of the proximal femur while preparing the implant bed. Approval had been obtained from the local Ethics Committee.
Primary cultures of human bone cells were prepared from the bone specimens as previously described. 13, 14 In brief, trabecular fragments from the proximal femur were cut into pieces, thoroughly rinsed in phosphate-buffered saline (PBS; 18 mM CaC1 2 , 0.2 mM MgC1 2 ) and kept in Dulbecco's minimum essential medium (Biochrom, Berlin, Germany) supplemented with 10% fetal calf serum (FCS), glutamine (58.5 µg/ml), penicillin (100 U/ml) and streptomycin (100 µg/ml). Cultures were initiated within three hours and fed twice weekly. These cells were shown to produce alkaline phosphatase, procollagen I and low levels of osteocalcin under basic conditions. After stimulation with 1,25 vitamin D3, levels of osteocalcin increased 20-fold. 14 Cells from the explants grown on to culture dishes were released from the surface after 14 to 21 days using 0.25% trypsin/EDTA (5 min, 37°C); medium was then added to stop trypsinisation. After centrifugation (15 min, 26‫ן‬g), they were placed in two 75 ml culture flasks, maintained at 37°C in a humidified 95% air/5% CO 2 atmosphere and defined as first-passage cells. After growth to 100% confluence, they were passaged as described above, counted and adjusted to a density of ‫01ן1‬ 5 cells/ml for the following experiments. They were then referred to as secondpassage cells. Culture of osteoblast-like cells in the presence of metal particles. A powder of the titanium alloy (Ti6Al4V alloy Iso 5832-3; Sulzer Orthopaedics AG, Winterthur, Switzerland) used in the prosthesis was prepared as described and characterised previously. 15 The mean size of the particles was 1 to 3 µm. The powder was suspended to a concentration of 12 mg/ml in a medium with 30% FCS after which 100 nl were placed in the middle of a 96-tissue-culture well and air-dried; 100 µl of the cell suspension were added and cells were cultivated as described before. Particle-free cultures served as a control. Once a week half of the medium was replaced. Human osteosarcoma cells (HOS 58), provided by Professor Dr A. Schultz (Department of Pathology, University of Giessen, Germany), were used for comparison. 16, 17 HOS 58 cells were plated at a density of ‫01ן1‬ 5 cells/ml and cultivated in ISCOVE's medium (Biochrom) supplemented with 10% FCS, 1% glutamine, penicillin (100 U/ml) and streptomycin (100 µg/ml) either in the presence or absence of metal particles. Human monocytes were obtained from freshly heparinised blood of healthy donors provided by the blood bank by standard methods, as described elsewhere, using density-gradient centrifugation with Ficoll Hypaque (Biochrom).
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Reagents. All cell-culture media and FCS were purchased from Biochrom. Cell-culture disposables were purchased from Nunc (Roskilde, Denmark) or Greiner (Solingen, Germany) and medium supplements (antibiotics, glutamine) from Gibco/BRL (Eggenstein, Germany). Standard laboratory reagents were purchased from Sigma (Münich, Germany), if not noted otherwise. Antibodies were purchased as follows: mouse anti-human BAP (Metra, Mountain View, California), anti-MHC I, -MHC II (DAKO, Glostrup, Denmark), anti-CD68 (Clone EMB11, DAKO), peroxidase (PO)-conjugated sheep anti-mouse IgG (Amersham, Braunschweig, Germany), AP-conjugated goat antimouse IgG (DAKO) and FITC-conjugated goat anti-mouse IgG (Sigma). Immunocytochemical studies. Mouse anti-human BAP, 1:100, was used as a marker for human osteoblast-like cells and mouse anti-CD68, 1:100, as an established marker for the monocytic lineage. For secondary antibodies we used PO-conjugated sheep anti-mouse IgG, 1:100, and AP-conjugated goat anti-mouse IgG, 1:100. Cell cultures were washed with PBS and then fixed for 30 minutes with 90% ethanol + 5% acetic acid + 5% deionised water. For blocking unspecific binding we used 10% normal swineserum (DAKO) in PBS (15 to 30 min) and for antibody dilution PBS plus 1% bovine serum albumin. The primary antibodies were incubated overnight at 4°C and the secondary antibodies for 30 minutes at room temperature. The POstaining was developed with H 2 O 2 and diaminobenzidine (DAB) (Amersham). For AP-conjugated secondary antibodies the staining was performed with naphthol/Fast Red (Sigma). This substrate kit contains levamisole to inhibit endogenous alkaline phosphatase activity. Controls were produced by omitting the primary antibody. Monocyte cultures served as positive control for anti-CD68 as well as a negative control for anti-BAP. For immunodoublestaining (CD68 and BAP) after the first staining procedure the preparation was washed extensively with washing buffer, and the next immunostaining was performed using a differently conjugated secondary antibody. Cell proliferation assay and immunodoublestaining for specific cell markers. Cell proliferation was determined by incorporation of the thymidine analogue, BrdU, for 24 hours into the proliferating nuclei followed by immunocytochemical staining by the PO-technique using a commercial kit (RPN 20, Amersham). The additional immunocytochemical detection for CD68 or BAP was performed as described before. Detection of TRAP. To exclude the presence of contaminating osteoclasts or macrophages in the osteoblastic cell cultures we carried out the enzymocytochemical detection of acid phosphatase and TRAP activity using a test kit from Sigma according to the manufacturer's instructions. The enzyme reaction was carried out for 20 minutes at room temperature.
Tartrate is an inhibitor of acid phosphatase. The tartrateresistant isoform of the acid phosphatase is physiologically expressed in alveolar macrophages and osteoclasts. Freshly isolated blood monocytes are negative for TRAP. After several days in culture when differentiated into macrophages, they become partially positive for TRAP depending on culture conditions. Fluorescence-activated cell scanning (FACS). This was performed as previously described. 19 Cells were trypsinised (see above), washed twice (8 min, 300‫ן‬g) in PBS and thereafter incubated in PBS with 4% formaldehyde (10 min, 4°C). After centrifugation the cell suspension was adjusted to a concentration of ‫01ן1‬ 5 cells/ml; 100 µl (10 4 cells per sample) were then pipetted into a well of a 96-well microplate (V-shape bottom). For detection of cytoplasmatic antigens, cells were made permeable with 0.1% saponin/PBS. After incubation with the protein-specific primary antibody (1:50), they were washed twice (6 min, 300‫ן‬g) with 160 µl of PBS (0.1% saponin). The secondary FITC-conjugated antibody was preabsorbed with human sera (antibody/sera 4:1) for 60 minutes at room temperature in darkness and then incubated for 20 minutes in similar conditions. The labelled cells were washed twice in PBS (0.1% saponin) and then resuspended in 600 µl of PBS (1% formaldehyde). To detect any changes in cell size (forward cell scatter) or cell granularity (sidewards cell scatter) caused by antibodies or chemicals one control was always incubated with PBS (0.1% saponin) only. Each analysis was done in triplicate and the results are given as the mean ± SD.
To test further for any non-specific binding of the FITClabelled secondary antibody (goat anti-mouse; Sigma), the cells were incubated with the preabsorbed secondary antibody only and any staining in these samples was defined as non-specific binding. In addition, we used mouse antihuman thyroglobulin as a negative control.
An FACS analyser (FACScan 81553; Becton-Dickinson Immunocytochemistry Systems, Mountain View, California) was used for analysis of fluorescent cells based on the reading of 5000 events (any particle detectable by the FACScan) per sample. In all experiments, the FACScan (gain, amplifier and photomultiplier voltage) was kept at a constant setting. Analysis was carried out with FACScan Research 
Results
Phagocytosis. In all four normal human osteoblast-like cell cultures, as well as in HOS 58 cultures, the cells incorporated the dispersed metal particles at all the times investigated (Figs 1a to 1c) . After 24 hours, the particles seemed to be diffusely and randomly distributed within the cell (Fig. 1a) . With increasing culture time storage of the particles then became well organised within the cytoplasm with a perinuclear location. Particles were also often concentrated at one side of the cell and always absent from the nucleus (Fig.  1b) . Around the cells there was a particle-free zone because of phagocytosis. The cultures were observed for up to four weeks. In that time all the cells, even those heavily laden with metal particles, had a vital appearance without any morphological changes; they were not rounded up nor did they lose their adherence to the substratum. Immunocytochemistry. Immunostaining for the osteoblast marker BAP had a distribution of staining ranging from faintly positive to intensive in cells exposed to metal (Figs 1a and 1b) as well as in untreated cultures. The intensity of staining also varied between the different donors. In HOS 58 cells (Fig. 1c) Human osteoblast-like cells were cultured in the presence of TiAlV particles for 1 (a), 3 (b) and 5 (c) days. On day 1 (a) none of the cells was positively stained, on day 3 (b) some cells were heavily stained while others were only slightly positive and on day 5 (c) most of the CD68 antigen was associated with fine granules in the cytoplasm except for the area around the nucleus (HE counterstaining). Six-day-old macrophages show a different staining pattern for CD68 (d) (bar = 50 µm).
negative for BAP (not shown). In negative controls using the secondary antibody only no substrate reaction was visible (not shown).
On the first day after starting the second passage, all cells were negative for the macrophage marker CD68 (Fig. 2a) , but positive for phagocytosis. On day three some of the human osteoblasts were slightly positive for CD68 and some of the cells stained more intensively (Fig. 2b) . On day 5, an increased number of cells showed a granular staining within the cytoplasm except for the perinuclear region (Fig.  2c) . By contrast, in six-day-old macrophages the CD68 antigen was always closely associated with the nucleus (Fig. 2d) . In normal osteoblastic cells the intensity of immunostaining for CD68 varied within a single culture as well as between the different donors. We did not find a correlation between phagocytosis of metal particles and the expression of the CD68 antigen. Apart from a diffuse background staining, HOS 58 cells were negative for CD68 at any time tested.
The immunodoublestaining technique in osteoblast-like cells showed the occurrence of both antigens, CD68 and BAP, within one cell (Fig. 3) . Distribution of cell markers to proliferating cells. We carried out the BrdU cell proliferation assay after immunodoublestaining for cell markers at different time points during the second passage. A variable number of cells with BrdU-positive nuclei were stained for BAP or CD68. The proliferation activity was moderate and was not influenced by the metal particles since even heavily laden cells showed incorporation of BrdU (not shown). TRAP activity. In normal osteoblastic cells as well as in HOS 58 cultures, no TRAP-positive cells were found (not shown). By contrast, in a six-day macrophage culture about half of the cells were positive. For the non-inhibited acid phosphatase almost all cells in normal osteoblasts, HOS 58 and macrophage cultures were positive.
Flow cytometry using FACS analysis. On day 9 a high number of cells from donor 1 were positive for CD68 (94.6%), but less than 1% were positive for MHC-II, which is normally present on macrophages and other antigenpresenting cells. In the second donor a time-dependent increase in CD68-positive cells was seen starting at 0.6% on day 3, rising to 3.6% on day 9 and to 61% on day 18 (Table I) . Only a small number of HOS 58 cells (up to 7.4% on day 18) were positive for CD68 (not shown). Phagocytosed titanium particles had no effect on the number of CD68-positive cells in either model.
Discussion
Phagocytosis of titanium particles by the osteoblastic sarcoma cell line MG 63 has recently been reported by Yao et al. 20 Our results have shown that normal human osteoblastlike cells as well as the osteosarcoma cell line HOS 58 were clearly able to phagocytose small particles of titanium alloy. There was a well-organised perinuclear storage of massively phagocytosed metal particles in the human osteoblasts and HOS 58 cells, which were identified by expression of the specific marker BAP by immunocytochemistry. The presence of haematopoietic cells was minimised by the preparation method. Contamination with macrophages was excluded by the absence of MHC-II in the FACS analysis as well as by the lack of TRAP activity which was present in macrophage cultures. Saad et al 21 described limited phagocytosis of degradation particles of polyesterurethane foam by primary rat osteoblasts and the mouse osteogenic cell line MC3T3-E1 without any signs of cellular damage or reduced ability for adhesion. In addition, phagocytosis by osteoblasts has been reported for particles of synthetic calcium phosphate, 22, 23 calcified bone matrix and collagen fibrils suggesting a possible participation of osteoblasts in bone resorption. 23 We did not observe a striking change in the behaviour of the osteoblasts. They did not actively migrate to the particles which were concentrated centrally at the surface of the culture well by our method of application. Although massively laden with phagocytosed metal particles, the morphology, viability and cell growth of the osteoblasts did not change. The cells were not rounded up nor did they lose their adherence to the substratum. Neither the histochemically-detected activity for acid phosphatase nor the immunostaining for BAP appeared to be influenced by the metal particles. Osteoblasts therefore seem to be able to phago- Immunodoublestaining for CD68 (PO staining, brown, arrow) and BAP (AP staining, red) show the coexpression of both antigens in one cell (bar = 50 µm). Anti-CD68 has been described to react predominantly with intracytoplasmatic structures of granular appearance. 9, 10 In spite of a close haematopoietic relationship between monocytes and granulocytes which are rich in cytoplasmic granules, anti-CD68 reacts only faintly, if at all, with the latter cell type. 9 In osteoblasts, CD68 was located within the cytoplasm. It was clearly associated with granules but left a free zone around the nucleus whereas in macrophages it appeared to be in close peri-or juxtanuclear contact. Thus, the staining pattern of CD68 may be important for discriminating between monocytes/macrophages and cells of non-myeloid or haematopoietic origin. CD68 is commonly used for discriminating histiocytes (macrophages) from other cells such as fibroblasts or osteoblasts in tissue sections which are CD68-negative. Nonmyeloid cells staining positively for CD68 were shown to be pathologically transformed, e.g. CD68 was found histopathologically in atypical fibroblasts in cases of fibrohistiocytic tumours, dermatofibromas, atypical decubital fibroplasia and fibrosarcomas. [25] [26] By contrast, we found only a slight positivity of CD68 in the transformed cell line HOS 58. Wang et al 27 found monocyte-associated antigens including CD68 in hepatic neoplastic cell lines of low differentiation whereas in higher differentiated lines CD68 was not present. The fetal liver is the main haematopoietic tissue during early pregnancy, and hepatocytes and haematopoietic cells share a common embryonic stem cell at early developmental stages. 28 Therefore the expression of monocytic antigens may be a differentiation marker for hepatocytes at immature stages. To our knowledge, the only normal non-myeloid cells which have been described as expressing a strong immunohistochemical reaction to CD68 are human retinal pigment epithelial cells. In contrast to the pathologically transformed cells described above, these cells are involved in scavenging processes by phagocytosis of aged outer-segment membranes and share a panel of immunophenotypic antigen expression including HLA-DR, CD11c and CD14 with monocytes/macrophages. 29 The differentiation capacity of bone cells seems to have been underestimated in the past. Human bone-marrow fibroblasts have recently been shown to be able to differentiate into either adipocytes or osteogenic cells. 30 Also, transformation of macrophages into fibroblasts has been described in a case of osteomyelosclerosis. 31 In our experiments, osteoblast-like cells express the macrophage marker CD68 and show phagocytic capacity in long-term culture. In vitro, cell differentiation in various directions is influenced by culture conditions. This was shown using freshly isolated monocytes which became slightly primed for activation by adherence to the surface of a plastic culture well, although the latter materal is considered to be inert. 32 Accordingly, primary osteoblasts in long-term culture, exposed to an artificial substratum, may undergo inherent functional and phenotypic changes. This may reflect the inherent epigenetic potential of the osteoblast-like cells as has been shown by others concerning the onset of proliferation activity of these cells in vitro, which under normal conditions in vivo are predominantly in a resting state. 33 Therefore the situation in vitro may reflect that in vivo when osteoblasts are in contact with endoprosthetic material. Our observations suggest that in vitro human osteoblastlike cells may undergo transdifferentiation into a phagocytosing cell under certain circumstances. Phagocytosis may be an underestimated inherent property of the osteoblast-like cell.
From these data we speculate that osteoblasts of a mixed phenotype, combining markers of osteoblasts and macrophages, may be part of the tissue surrounding failed orthopaedic implants. In vivo studies on cells of histiocytic appearance with phagocytosed metal particles around endoprostheses should be given careful consideration when using anti-CD68 for identifying macrophages. In order to discriminate between macrophages and osteoblasts additional markers should be used. Further investigation will be necessary to clarify the role of osteoblasts around periprosthetic tissue with respect to net bone formation. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
